Novo Nordisk -66% Can Buy?
1 extracted signal · 1 resolved · 0 still active
Boon TeeIndependent analyst profile- Source published
- 17 Aug 2025, 01:29 UTC
- Recorded by Tahlil Plus
- 30 Jul 2026, 10:59 UTC

AI-generated source summary
The analysis focuses on Novo Nordisk (NVO), identifying a bearish trend on the daily chart. The stock experienced a significant drop from a peak around 150 to a current price of approximately 50.89. The analyst notes a V-shape recovery pattern. The primary risk identified is the potential for the stock price to invalidate the bullish setup if it falls below a certain level. The stock is presented as a potential bullish trade, with a target price that is not explicitly stated but implied by the bullish sentiment, and a stop-loss level to invalidate the trade, which would be below the current support level.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Boon Tee
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
